Please login to the form below

Not currently logged in
Email:
Password:

drug abuse

This page shows the latest drug abuse news and features for those working in and with pharma, biotech and healthcare.

Trump pledges ‘total victory’ in war on drug prices

Trump pledges ‘total victory’ in war on drug prices

Trump pledges ‘ total victory’ in war on drug prices. Despite rhetoric against pharma and PBMs, shares rise as markets shrug off threats to sector. ... In his speech, Trump described the current “broken system”of medicines delivery as an

Latest news

  • FDA panel backs Indivior’s drug to fight opioid addiction FDA panel backs Indivior’s drug to fight opioid addiction

    FDA panel backs Indivior’ s drug to fight opioid addiction. The former RB pharma unit hopes for sales in the $1bn region. ... Indivior is on course to bring a new drug to market to tackle painkiller addiction in the US, offsetting the risks to its

  • FDA panel backs Pfizer and Teva abuse-resistant painkillers FDA panel backs Pfizer and Teva abuse-resistant painkillers

    However, it would not back a label claim that the product could prevent abuse of the drug via the oral route, but said it could discourage abuse by people seeking to ... Last month the same panel also rejected an abuse-deterrent claim for KemPharm's

  • FDA gives green light for opioid addiction implant FDA gives green light for opioid addiction implant

    He added: “ Opioid abuse and addiction have taken a devastating toll on American families. ... Nora Volkow, director of the National Institute on Drug Abuse, said: “ Scientific evidence suggests that maintenance treatment with these medications in

  • FDA panel backs Novo Nordisk's liraglutide for obesity FDA panel backs Novo Nordisk's liraglutide for obesity

    FDA panel backs Novo Nordisk's liraglutide for obesity. Committee says diabetes drug could be used to reduce weight. ... Orexigen said yesterday that Contrave will have the benefit of a large Takeda salesforce promoting the drug and no need for

  • Acura must provide FDA more info on pain drug Acura must provide FDA more info on pain drug

    Acura must provide FDA more info on pain drug. Regulator questions abuse-resistant ability of Aversion. ... The FDA has demanded that Acura Pharmaceuticals submit more evidence on the abuse-deterrent abilities of its investigational pain drug.

More from news
Approximately 3 fully matching, plus 28 partially matching documents found.

Latest Intelligence

  • Pharma deals during January 2013 Pharma deals during January 2013

    9.5. Savant HWP / National Institute on Drug Abuse. Development grant. ... 18-MC (18-methoxycoronaridine) as a treatment for drug addiction, obesity and compulsive behaviour.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • "Legal highs" ruling leaves illegal labs laughing

    We have also pitched for agents designed to treat opioid overdose and alcohol abuse. ... Drug abuse is a massive medical and social problem in the UK, and it has been compounded by the availability of new psychoactive agents virtually everywhere.

  • "Legal highs" ruling leaves illegal labs laughing

    We have also pitched for agents designed to treat opioid overdose and alcohol abuse. ... Drug abuse is a massive medical and social problem in the UK, and it has been compounded by the availability of new psychoactive agents virtually everywhere.

  • How digital content is helping physicians curb the opioid abuse epidemic

    using their state’ s Prescription Drug Monitoring Program (PDMP) database before prescribing opioids to a patient. ... After all, having physicians more frequently access these state PMDPs at the point of prescription can go a long way to preventing

More from PMHub
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics